Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Ou connectez-vous avec votre réseau social favori

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

MIRNAX BIOSENS, S.L.

MIRNAX BIOSENS, S.L._logo
7
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

MIRNAX BIOSENS is a biotech company that develops new technologies, based on liquid biopsy, for the fast and direct diagnosis and prognosis of pathologies without an effective current method.

MADRID, MADRID, Spain

Send a message

Anglais

MIRNAX BIOSENS, S.L.

Anglais

MIRNAX BIOSENS is a biotech company that develops new technologies, based on liquid biopsy, for the fast and direct diagnosis and prognosis of pathologies without a effectice current method.

MIRNAX has developed an innovative technological platform that allows the detection of genetic markers from non-invasive biological samples such as blood, urine or saliva (liquid biopsy).This platform, MiRNAX platform

See more

MIRNAX BIOSENS is a biotech company that develops new technologies, based on liquid biopsy, for the fast and direct diagnosis and prognosis of pathologies without a effectice current method.

MIRNAX has developed an innovative technological platform that allows the detection of genetic markers from non-invasive biological samples such as blood, urine or saliva (liquid biopsy).This platform, MiRNAX platform, is based on RT-qPCR technology and it provides an integral solution that covers all phases of the process:

  1. Sample preparation: nucleic acid extraction and preservation technology included 
  2. Amplificationn: suitable amplification of genetic markers, such as DNA, RNA, miRNAs, lnRNAs, etc. (PCR).
  3. Detection: quantification of genetic markers in real time (qPCR).

In terms of exploitation of the MiRNAX platform, the company has developed different diagnostic and/or prognostic kits for the detection of diseases and clinical conditions whose diagnosis through the identification of miRNA type biomarkers is possible and it is implanted or in the process of implantation within the medical-scientific community.

The first kit that the company will launch is a test for the early diagnosis of acute kidney injury, a disease that currently lacks an effective method for diagnosis and that negatively compromises the patients' lives.

Mirnax Biosens is starting the semi-clinical validation of this first kit.

  • 1

    Followers

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1012 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected deep tech companies.
234 Members
Communauté Bpifrance
ADVENTURE, IT'S FRANCE! Dynamizing and making the French economy more competitive is the role of Bpifrance Entrepreneurs, welcome!
2107 Members